GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DongKook Pharmaceutical Co Ltd (XKRX:086450) » Definitions » E10

DongKook Pharmaceutical Co (XKRX:086450) E10 : ₩0.00 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is DongKook Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

DongKook Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩192.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩0.00 for the trailing ten years ended in Dec. 2024.

During the past 12 months, DongKook Pharmaceutical Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of DongKook Pharmaceutical Co was 11.40% per year. The lowest was 9.20% per year. And the median was 9.95% per year.

As of today (2025-04-04), DongKook Pharmaceutical Co's current stock price is ₩14990.00. DongKook Pharmaceutical Co's E10 for the quarter that ended in Dec. 2024 was ₩0.00. DongKook Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of DongKook Pharmaceutical Co was 45.51. The lowest was 13.61. And the median was 22.82.


DongKook Pharmaceutical Co E10 Historical Data

The historical data trend for DongKook Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DongKook Pharmaceutical Co E10 Chart

DongKook Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 732.46 820.61 921.71 1,011.54 -

DongKook Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,011.54 1,040.29 - - -

Competitive Comparison of DongKook Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, DongKook Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DongKook Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DongKook Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where DongKook Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

DongKook Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DongKook Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=192/121.1352*121.1352
=192.000

Current CPI (Dec. 2024) = 121.1352.

DongKook Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201503 122.000 99.721 148.199
201506 119.000 100.051 144.078
201509 184.400 100.111 223.126
201512 198.600 100.220 240.045
201603 191.600 100.561 230.800
201606 226.000 100.791 271.618
201609 250.600 101.461 299.193
201612 256.800 101.561 306.293
201703 186.200 102.851 219.302
201706 216.400 102.611 255.466
201709 206.800 103.491 242.059
201712 291.600 102.991 342.973
201803 233.800 104.101 272.058
201806 243.200 104.130 282.916
201809 267.400 105.651 306.592
201812 315.400 104.351 366.131
201903 279.200 104.491 323.674
201906 271.600 104.881 313.692
201909 67.400 105.200 77.609
201912 377.446 105.121 434.945
202003 74.000 105.354 85.084
202006 59.800 105.112 68.916
202009 381.000 106.198 434.591
202012 205.049 105.765 234.847
202103 338.000 107.357 381.378
202106 253.000 107.579 284.882
202109 190.000 108.759 211.621
202112 345.000 109.676 381.045
202203 351.000 111.848 380.145
202206 358.000 114.072 380.166
202209 264.000 114.715 278.774
202212 210.000 115.179 220.859
202303 358.000 116.507 372.220
202306 222.000 117.182 229.489
202309 271.000 118.964 275.947
202312 203.000 118.837 206.926
202403 440.000 120.123 443.707
202406 304.000 120.007 306.857
202409 431.000 120.861 431.977
202412 192.000 121.135 192.000

Add all the adjusted EPS together and divide 10 will get our e10.


DongKook Pharmaceutical Co  (XKRX:086450) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of DongKook Pharmaceutical Co was 45.51. The lowest was 13.61. And the median was 22.82.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


DongKook Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of DongKook Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


DongKook Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Dongkook Building 997-8 Daechi 3-dong, Kangnam-gu, Seoul, KOR, 135-502
DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.

DongKook Pharmaceutical Co Headlines

No Headlines